by Kate Knibbs | May 15, 2025 | News
After telehealth startups recently lost the ability to sell exact copies of patented GLP-1 weight-loss drugs, some firms have begun turning to a different, less effective medication that has been on the market in the United States since 2010. Often considered a...
by Zoë Schiffer, Emily Mullin, Will Knight | May 7, 2025 | News
The Food and Drug Administration (FDA) has been meeting with OpenAI to discuss the agency’s use of AI, according to sources with knowledge of the meetings. The meetings appear to be part of a broader effort at the FDA to use this technology to speed up the drug...
Recent Comments